Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-01 02:28:34 - browse：89

Marc Tessier Lavigne (center) retracted two Science papers on the day his resignation as Stanford president takes effect. Mattarella in San Francisco

After an expansive investigation found manipulated data and other issues with papers co-authored by Stanford’s now ex-president Marc Tessier-Lavigne, the prominent neuroscientist on Thursday retracted two studies published in the journal Science in 2001 — over the objection of a former postdoctoral researcher who played a leading role in both projects.

The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect. His departure was prompted by a 95-page report released by a special committee of the university’s Board of Trustees, which recruited outside scientists and a former federal judge to investigate a dozen papers Tessier-Lavigne co-authored between 1999 and 2009, years before becoming the university’s leader.

The panel concluded that he did not personally engage in scientific misconduct, but it uncovered manipulated data in some studies Tessier-Lavigne had supervised and found that he took insufficient steps to “decisively and forthrightly” correct these studies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： CDC marks new Covid

focus

WSS

Gene therapy has helped boys walk. Can scientists keep it that way?

Novo Nordisk obesity pill bests Wegovy in early trial

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Gene therapy has helped boys walk. Can scientists keep it that way?

Headspace, Meta partner to launch VR meditation app for Quest

Why drug prescriptions should include diagnoses

hotspot

Wikipedia

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Drug repurposing or repositioning? The language matters

With FDA staff opposed to Sarepta therapy, top official intervened

Peter Hotez and the public health issue of online harassment

The story of mRNA: From a loose idea to a tool that may help curb Covid

How to save PrEP access — and even expand it

Death of patient in Alzheimer’s trial raises question of possible risks

Trump demands the U.S. pay no more for drugs than other countries … again

Amylyx ALS drug fails large clinical trial

focus

How to bring more disabled researchers into academia

A deep dive into Applied Therapeutics’ data, and questions on Cassava

What it’s like to watch children die of measles

The science behind Janet Jackson's pregnancy at 49

UnitedHealth quietly bought dozens of outpatient centers

New guidelines on severe brain injury complicate already difficult decisions

focus

focus

Wikipedia

hotspot